Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04480580

Enrollment

100

Registered

2020-07-21

Start date

2020-03-30

Completion date

2020-06-30

Last updated

2020-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, SARS (Severe Acute Respiratory Syndrome), Surgery

Keywords

SARS-CoV-2, surgery

Brief summary

We have herein analysed the patients admitted to our Department that underwent serologic tests for SARS-CoV-2 either by Ab or RT PCR, to estimate the prevalence of COVID-19 in the setting of a non-dedicated COVID-19 hospital and in a low CoV-2 incidence area, and to evaluate if security measures are necessary for this context.

Interventions

DIAGNOSTIC_TESTSARS-CoV-2 Ab

Patient test for specific antibodies for SARS-CoV-2

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Patients hospitalized during pandemic spread

Exclusion criteria

* Incomplete data

Design outcomes

Primary

Measure	Time frame	Description
Seroprevalence of SARS-CoV-2	3 months	Positivity of specific IgM or IgG

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026